Recent News

• 02.14.2025 - Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
• 12.23.2024 - Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise
• 11.13.2024 - Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates
• 09.25.2024 - Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates

Recent Filings

• 02.14.2025 - EX-99.1 EX-99.1
• 02.14.2025 - 8-K Current report
• 02.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.12.2025 - 8-K Current report
• 12.31.2024 - D Notice of Exempt Offering of Securities
• 12.26.2024 - 4 Statement of changes in beneficial ownership of securities
• 12.26.2024 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 12.23.2024 - EX-99.1 EX-99.1
• 12.23.2024 - 8-K Current report